Evolving Trends in Medication Assisted Treatment for Opiate Use Disorder

Last year there were 66,000 opiate overdose deaths in the US and these numbers appear to be continuing to rise. Medication assisted treatment has been shown to reduce mortality for those with an opiate use disorder. This training reviews the different medication options including Methadone maintenance, Buprenorphine maintenance and Extended release Naltrexone (Vivitrol). Efficacy and potential pitfalls of different treatment options will be explored. The training will also review patient selection for the different treatment options. Recent data comparing the efficacy of Buprenorphine maintenance vs Extended release Naltrexone will be presented. Several studies have shown a spike in overdose deaths following release from prison and residential treatment. Implementing MAT in different settings, such as inpatient treatment and for those who are incarcerated is potentially lifesaving. Pregnant women with an opiate use disorder is a challenging population to treat. MAT options for this population will be discussed. Finally, the expanding use of Narcan will also be discussed.

Friday, May 17, 2019 - 9:00am to 4:00pm
PCB Hours Approved: 
6 hrs
Christopher Davis, D.O. FASAM, CAADC
Go to top